ENLIVEN THERAPEUTICS INC

Ticker: ELVN CUSIP: 29337E102 Class: Common Stock

Bank of New York Mellon Corp's Holding History (CIK: 0001390777)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 110,569 Value ($000) $1,703 Avg Close $19.92 Range $15.14 - $24.64

Q3 2025

Shares 115,616 Value ($000) $2,367 Avg Close $20.16 Range $17.43 - $24.38

Q2 2025

Shares 98,129 Value ($000) $1,968 Avg Close $18.93 Range $13.30 - $24.11

Q1 2025

Shares 93,567 Value ($000) $1,841 Avg Close $21.52 Range $18.67 - $25.37

Q4 2024

Shares 89,575 Value ($000) $2,015 Avg Close $25.92 Range $21.43 - $30.03

Q3 2024

Shares 90,403 Value ($000) $2,309 Avg Close $23.16 Range $20.63 - $27.67

Q2 2024

Shares 114,109 Value ($000) $2,667 Avg Close $21.05 Range $15.96 - $26.00

Q1 2024

Shares 76,477 Value ($000) $1,345 Avg Close $15.34 Range $10.90 - $19.50

Q4 2023

Shares 80,129 Value ($000) $1,109 Avg Close $12.23 Range $9.80 - $15.41

Q3 2023

Shares 80,759 Value ($000) $1,103 Avg Close $16.84 Range $12.38 - $20.77

Q2 2023

Shares 80,924 Value ($000) $1,652 Avg Close $20.21 Range $17.15 - $23.98

Q1 2023

Shares 15,295 Value ($000) $335 Avg Close $20.34 Range $14.56 - $25.34

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	110,569	$1,703	$19.92	$15.14 - $24.64
Q3 2025	115,616	$2,367	$20.16	$17.43 - $24.38
Q2 2025	98,129	$1,968	$18.93	$13.30 - $24.11
Q1 2025	93,567	$1,841	$21.52	$18.67 - $25.37
Q4 2024	89,575	$2,015	$25.92	$21.43 - $30.03
Q3 2024	90,403	$2,309	$23.16	$20.63 - $27.67
Q2 2024	114,109	$2,667	$21.05	$15.96 - $26.00
Q1 2024	76,477	$1,345	$15.34	$10.90 - $19.50
Q4 2023	80,129	$1,109	$12.23	$9.80 - $15.41
Q3 2023	80,759	$1,103	$16.84	$12.38 - $20.77
Q2 2023	80,924	$1,652	$20.21	$17.15 - $23.98
Q1 2023	15,295	$335	$20.34	$14.56 - $25.34